Risk factor
Resilient to price shocks
Profitability factor
Greatly undervalued vs peers
About
Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary...
Company Valuation
Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITD
Target Price
The average target price of ACL.AX is 3.5 and suggests 46% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incre
Buy
Sell